A randomized controlled trial of green tea extract supplementation and mammographic density in postmenopausal women at increased risk of breast cancer
Cancer Prevention Research Nov 10, 2017
Samavat H, et al. - A randomized, double-blinded, placebo-controlled phase II clinical trial was performed to determine whether supplementation with green tea extract (GTE) modifies mammographic density (MD) in postmenopausal women at increased risk of breast cancer. In this study, 1-year supplementation with a high dose of epigallocatechin-3-gallate (a constituent of green tea extract capsules) seemed not having a significant effect on MD measures in all women, but reduced percent MD in younger women, an age-dependent effect similar to those of tamoxifen. Findings justified further investigation of the potential chemopreventive effect of green tea intake on breast cancer risk in younger women.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries